Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v5-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-01-26 | 2020-11-03 |
| Drug Identification Number | 02139545 | 02139545 |
| Brand name | POTASSIUM PHOSPHATES INJECTION, USP | POTASSIUM PHOSPHATES INJECTION, USP |
| Common or Proper name | Potassium Phosphates Injection | Potassium Phosphates Injection |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | POTASSIUM PHOSPHATE MONOBASIC POTASSIUM PHOSPHATE DIBASIC | POTASSIUM PHOSPHATE MONOBASIC POTASSIUM PHOSPHATE DIBASIC |
| Strength(s) | 224MG 236MG | 224MG 236MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 50 mL | 50 mL |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-11-02 | 2020-11-02 |
| Actual start date | ||
| Estimated end date | 2020-12-21 | 2020-12-04 |
| Actual end date | 2021-01-22 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Potassium Phosphates Injection, USP, 3 mmol/mL, Phosphorus SD Vial, 50 mL we will be placing the following products on 50% allocation effective today, Tuesday, September 15, 2020. UPDATE 10/30: Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 50 mL. Estimated Stockout Date November 2, 2020 Estimated Availability Date December 4, 2020 Our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 15 mL vials will be placed on 100% allocation and allocations will be increased to cover the 50 mL demand on a 3:1 ratio (three 15mL vials to one 50mL vial). UPDATE 11/25: We will also be extending the backorder on our Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 50 mL until December 21, 2020. UPDATE We are also pleased to advise that replenishment inventories of our Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 50 mL have been released and the product will be placed on 100% allocation, effective December 22, 2020. Please note that Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 15 mL will remain on 100% allocation. | Potassium Phosphates Injection, USP, 3 mmol/mL, Phosphorus SD Vial, 50 mL we will be placing the following products on 50% allocation effective today, Tuesday, September 15, 2020. UPDATE 10/30: Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be encountering a supply interruption on our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 50 mL. Estimated Stockout Date November 2, 2020 Estimated Availability Date December 4, 2020 Our Potassium Phosphates Injection, USP, 3 mmol/mL Phosphorous SD Vial 15 mL vials will be placed on 100% allocation and allocations will be increased to cover the 50 mL demand on a 3:1 ratio (three 15mL vials to one 50mL vial). |
| Health Canada comments |